The Program Chairs for the American College of Osteopathic Surgeons’ (ACOS) 2024 General Surgery In-depth Review Seminar (IDR), Igor G. Elyash, DO, and Victoria L. Schlanser, DO, FACOS, FACS, along with the full support of the ACOS In-depth Review Committee have developed a first-rate board exam review course.
IDR sessions provide a deep dive into the topics covered in the American Osteopathic Board of Surgery (AOBS) and American Board of Medical Specialties (ABMS) General Surgery certification examinations. Our panel of presenters will discuss the purpose and focus of the exam as well as what examiners are looking for. The intent is to be a thorough review of the examination topics as well as an update for the general surgeon in practice in order to be able to practice in a safe and efficient manner. Participants in this course will find it a helpful experience in preparing for certification or recertification examinations.*
The 2024 IDR curriculum focuses on the topics covered on written surgical board examinations with the specific intent of being a thorough review of a wide range of topics, delivering a comprehensive update for the general surgeon in practice. The seminar will finish with an optional mock oral board session on Sunday, April 14. This interactive workshop is intended to assist physicians preparing to take their Oral Board Examinations.
* ACOS does not guarantee results on any certification or recertification exams.
General Surgeons need thorough knowledge of the most recent developments and techniques as well as established guidelines in surgery to ensure the highest standards of patient care and safety.
By participating in 2024 IDR educational programs and activities, attendees are eligible to earn American Osteopathic Association (AOA) Category 1A continuing medical education (CME) credits or AMA PRA Category 1 Credits™. In accordance with CME accreditation requirements, the attendee must complete an evaluation of each session attended as well as an overall event evaluation to receive CME credit. Physicians should only claim credit commensurate with the extent of their participation in each IDR educational program and/or activity. Instructions on how to access the online CME tracking and program evaluation system are distributed to registered attendees.
The American College of Osteopathic Surgeons (ACOS) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. Eligible attending physicians can earn American Osteopathic Association continuing medical education (CME) credit by participating in the educational programs and activities at the 2024 General Surgery In-depth Review Seminar. This program is approved for a maximum of 32 AOA Category 1-A CME credit hours. In accordance with the AOA CME accreditation requirements, the attendee must complete an evaluation of each session attended as well as an overall event evaluation in order to receive AOA CME credit. Physicians should only claim credit commensurate with the extent of their participation in the educational activity. Information on how participants can claim their CME hours will be provided to eligible attendees. After the program evaluation has been completed, a CME certificate can be printed by the registrant. ACOS will report CME credits equal to the extent of the physician’s participation in this activity to the AOA.
Any questions or concerns regarding the CME requirements, credits earned for this meeting, or problems such as facilities, handouts, and program content may be directed to the ACOS staff by calling (800) 888-1312. Unresolved issues regarding the compliance of this meeting with the AOA accreditation requirements may be brought to the attention of the AOA Division of CME by calling (888) 626-9262. Any formal action by the AOA will require a written communication from you.
The American College of Osteopathic Surgeons (ACOS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The ACOS designates this other [live, enduring] activity for a maximum of 32 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACOS managers Kathleen Fitzgerald, CMP, DES, and Emily Mathae have nothing to disclose.
The American College of Osteopathic Surgeons (ACOS) is accredited by the American Osteopathic Association (AOA). In accordance with the AOA Standards of Accreditation; and Accreditation Council for Continuing Medical Education (ACCME) Essential Criteria and Policies and Standards for Commercial Support; and AMA PRA Category 1 Credits™ guidelines, none of the planners, staff, speakers, or faculty have any relevant financial relationships to disclose except those listed in the faculty roster. Any relevant financial relationship has been mitigated in advance of the activity.
ACOS requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to ACOS policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
The opinions and ideas expressed by IDR speakers or found in any handout materials are those of the presenters and will not be endorsed or cannot claim to be endorsed by the American College of Osteopathic Surgeons, or their disciplines and sections.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
ACOS plans to take photographs/videos at the General Surgery In-depth Review Seminar and reproduce them in ACOS educational, news or promotional material, whether in print, electronic or other media, including the ACOS website. By participating in the ACOS General Surgery In-depth Review Seminar, you grant ACOS the right to use your name, photograph, and biography for such purposes. All postings become the property of ACOS. Postings may be displayed, distributed, or used by ACOS for any purpose.
Attendee understands that travel to and participation in the 2024 General Surgery In-depth Review Seminar (the “Meeting”) sponsored by the American College of Osteopathic Surgeons (“Sponsor”) is entirely voluntary and comes with inherent risks. In consideration of the right to attend the Meeting, Attendee assumes all risks and accepts sole responsibility for any injury (including, but not limited to, personal injury, disability, and death), illness, damage, loss, claim, liability, or expense, of any kind, that attendee may experience or incur in connection with attending the Meeting. Attendee has carefully considered the risk involved and hereby releases, covenants not to sue, discharges, and holds harmless the Sponsor and their respective officers, directors, employees, agents, and representatives, of and from any such claims, including all liabilities, claims, actions, damages, costs, or expenses of any kind (including reasonable attorney’s fees) arising out of or relating thereto.
Specifically relating to the global COVID-19 pandemic, Attendee acknowledges the highly contagious nature of COVID-19 and voluntarily assumes the risk of exposure or infection by attending the Meeting and understands that such exposure or infection may result in personal injury, illness, disability, and/or death to Attendee. Attendee understands that the risk of becoming exposed to or infected by COVID-19 at the Meeting may result from the actions, omissions, or negligence of others who may attend the Meeting or their families, guests, colleagues, or others with whom they may have contact. Accordingly, attendee understands and agrees that this release includes any claims based on the actions, omissions, or negligence of Sponsor and their respective officers, directors, employees, agents, and representatives, whether a COVID-19 infection occurs before, during, or after participation in the Meeting.
In addition to all other Sponsor rules and regulations relating to the Meeting attendance, Attendee agrees to comply with all COVID-related procedures that may be required by the venue facility. Attendee also agrees not to attend the Event if any COVID-related symptoms are experienced within ten days of the start of the meeting or if the Attendee may have been exposed to someone who has been diagnosed with COVID-19 or is experiencing COVID-19 symptoms.
By completion and submission of the meeting registration form, I certify that I have read and fully understand this Liability Waiver and Assumption of Risk agreement and understand that it affects my legal rights. I agree and acknowledge that this waiver and release (1) shall be binding on me, my guests, my heirs, family, estate, representatives, and assigns and (2) is intended to be as broad as permitted under applicable law, and each waiver or provision herein is severable and shall apply notwithstanding the invalidation of any other provision herein.
The American College of Osteopathic Surgeons (ACOS) is committed to providing its employees, directors and officers, volunteers, members, independent contractors, event participants, and event faculty (collectively, “covered persons”) with settings that are free from harassment in any form.
Prohibited conduct includes, but is not limited to: 1) harassment based on race, gender, sexual orientation, disability, or any other protected status, as provided by local, state, or federal law; 2) sexual harassment including unwelcome attention, stalking and physical contact; 3) abusive conduct that has the purpose or effect of unreasonably interfering with another person’s ability to enjoy or participate in the Conference, including social events related to the Conference; and 4) undue interruption of any Conference event, speaker or session.
Harassment takes many forms and may be, but is not limited to: words, signs, jokes, pranks, intimidation, physical contact, unwelcome sexual advances, requests for sexual favors, stalking, other verbal or physical contact of a sexual, aggressive, or hostile nature, vulgar or abusive language, or violence as it relates to race, national origin, religion, age, disability, gender, sexual orientation, or any other classification protected by local, state, or federal laws.
ACOS will not tolerate harassment of or by these individuals. Any conduct by a covered person towards another covered person that is intimidating, hostile, offensive, and/ or specifically prohibited by law is prohibited. Any covered person engaging in such conduct will be subject to disciplinary action, which may include termination of ACOS employment or as a contractor, member referral to the ACOS Ethics Committee, immediate expulsion from ACOS-sponsored events, removal as a director, officer, volunteer, or faculty member, or other actions as may be deemed appropriate.
The covered person(s) who believe that they have been the subject of any form of harassment should immediately report such conduct to the ACOS CEO, any member of the ACOS Executive Committee, or the chair of the ACOS-sponsored event at which the harassment allegedly occurred. Complaints alleging a violation of this policy by the ACOS CEO shall be made to the ACOS President.
Any covered person submitting a complaint must be acting in good faith and have reasonable grounds for believing the information disclosed indicates a violation of this policy. Any allegations that prove to have been made maliciously or knowingly to be false will be viewed as a serious disciplinary offense.
To instigate an investigation, a written statement of the incident(s) will be requested. ACOS will promptly investigate all reports of harassment and will keep the identity of the covered person(s) making the report and all aspects of the report and investigation confidential to the greatest extent possible. ACOS will take appropriate action(s) to remedy substantiated complaints.
ACOS will not condone any form of retaliation against any covered person who in good faith reports an alleged violation of this policy. A covered person who retaliates against someone who submits a complaint is subject to discipline, up to and including termination of ACOS employment/engagement, loss of position, and/or revocation of ACOS membership.
